June 18 (Reuters) - Swiss drugmaker Roche will team up with privately held biotech Ascidian Therapeutics to develop gene therapies targeting difficult to treat neurological diseases, the Boston-based startup said on Tuesday. WHY IT'S IMPORTANT Roche is pursuing several therapeutic fields to offset falling oncology sales, setting a high deal pace to restore its development pipeline that was hit by...

06:59 AM EDT, 06/18/2024 (MT Newswires) -- Julie Andrews, Director, on June 14, 2024, sold 15,625 shares in RxSight ( RXST ) for $906,288. Following the Form 4 filing with the SEC, Andrews has control over a total of 30,287 shares of the company, with 30,287 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1111485/000095017024074473/xslF345X03/ownership.xml ...

SMITH CENTER, Kansas (Reuters) - In a tiny town surrounded by miles of rippling wheat fields, Brady Peterson's restaurant sits nearly empty during what should be a Saturday lunch rush. Normally, Pete's would be filled with farmers ordering fried chicken and cheeseburgers, but as farm income thins, so does Peterson's business. Sluggish sales have slashed his income so much that...

07:00 AM EDT, 06/18/2024 (MT Newswires) -- SKRR Exploration ( SKKRF ) on Tuesday said it will commence a drill program of about five exploration core drill holes and ground gravity and Time Domain electromagnetic geophysical surveys at the Clearwater West project in Saskatchewan. SKRR has an option to acquire up to a 70% interest in Clearwater West from F3...